Fed Regist. 2015 May 15;80(94):27854-6.
The Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to extend the temporary placement of (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144), 1-(5-fluoro-pentyl)-1H-indol-3-ylmethanone (5-fluoro-UR-144, XLR11) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. The current final order temporarily placing UR-144, XLR11, and AKB48 in schedule I is due to expire on May 15, 2015. This final order will extend the temporary scheduling of UR-144, XLR11, and AKB48 to May 15, 2016, or until the permanent scheduling action for these three substances is completed, whichever occurs first.
美国药品管理局（DEA）局长发布本最终命令，以延长将（1-戊基-1H-吲哚-3-基）（2,2,3,3-四甲基环丙基）甲酮（UR-144）、[1-（5-氟戊基）-1H-吲哚-3-基]（2,2,3,3-四甲基环丙基）甲酮（5-氟-UR-144，XLR11）和N-（1-金刚烷基）-1-戊基-1H-吲唑-3-甲酰胺（APINACA，AKB48），包括其盐类、异构体以及可能存在的异构体盐类，临时列入《管制物质法》附表一的期限。当前将UR-144、XLR11和AKB48临时列入附表一的最终命令将于2015年5月15日到期。本最终命令将把UR-
